The concepts, diagnosis and management of early imaging changes after therapy for glioblastomas

Sanghera, P., Rampling, R., Haylock, B., Jefferies, S., McBain, C., Rees, J.H., Soh, C. and Whittle, I.R. (2012) The concepts, diagnosis and management of early imaging changes after therapy for glioblastomas. Clinical Oncology, 24(3), pp. 216-227. (doi: 10.1016/j.clon.2011.06.004)

Full text not currently available from Enlighten.

Abstract

Since postoperative radiotherapy plus concomitant temozolomide followed by adjuvant temozolomide has become standard treatment for glioblastoma, the phenomenon of early post-treatment enlargement of the imaged tumour volume, usually without clinical deterioration, has become widely recognised. The term pseudoprogression has been used to describe a poorly understood pathophysiological process. In this review, the pathophysiological concepts, relevance, diagnosis and management of patients with ‘pseudoprogression’ and ‘pseudoresponse’ are discussed. Guidelines are given with respect to radiological imaging modality, mode and frequency. Further biological and clinical insights into these phenomena require carefully designed prospective studies.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Rampling, Professor Roy
Authors: Sanghera, P., Rampling, R., Haylock, B., Jefferies, S., McBain, C., Rees, J.H., Soh, C., and Whittle, I.R.
College/School:College of Medical Veterinary and Life Sciences > School of Medicine, Dentistry & Nursing
Journal Name:Clinical Oncology
ISSN:0936-6555
Published Online:23 July 2011

University Staff: Request a correction | Enlighten Editors: Update this record